BEKHealth

What BEKHealth does

BEKhealth Corporation, founded in 2017 and headquartered in Branford, Connecticut, operates an AI-powered clinical intelligence platform purpose-built for clinical trial feasibility, patient recruitment, and real-world evidence generation. The company sells to pharmaceutical sponsors and contract research organizations (CROs) on a quote-based enterprise SaaS model, while offering its BEKnetwork free of charge to research sites and healthcare organizations as a two-sided marketplace. As of the most recent disclosure, the platform analyzes structured and unstructured electronic health record (EHR) data — including physician notes, pathology reports, and handwritten records — using proprietary deep-learning natural language processing (NLP) and large language models (LLMs) trained against a proprietary ontology built from 400+ medical libraries aligned with 70,000 clinical trial protocols. The same longitudinal patient record powers both patient matching and RWD generation.

The product portfolio centers on BEKplatform (the core AI engine for patient matching and feasibility), BEKnetwork (a connected research network spanning 30M+ patient records, 200+ sites, and 20,000+ clinicians), and a 2024-launched suite of workflow tools including Galileo (network feasibility), SiteWorks (research CRM), BEK Translate Real-Time (protocol translation), and BEKScore (protocol AI-compatibility scoring). The platform reports 95%+ accuracy reading structured and unstructured EHR data, 3× more accurate patient matching versus manual processes, 10× more qualified patients surfaced, and a demonstrated capability of matching 45,000 patients in seconds. Real-world data (RWD) is monetized as a separate revenue stream via data access agreements with sponsors and CROs, with daily refresh and built-in provenance.

Go-to-market combines direct enterprise sales to sponsors/CROs with channel distribution through EMR vendor approvals (17+ platforms including Epic, Cerner, Athenahealth), the CRIO Partners Program, and partnerships with WCG, Science 37, RTI Health Solutions, Innovo Research, and Areti Health. The company has raised approximately $8M to $19M in venture funding across multiple rounds since 2021 (Excelerate Health Ventures, Hatteras Venture Partners, Boston Millennia Partners, Martin Ventures, RTI International, WakeMed Innovation Fund, Change Healthcare), is privately held, and operates with 11–50 employees across Branford, Austin, Boston, and Raleigh. In 2024, David Levin was appointed President and CEO to lead the next phase of growth.

Name

BEKHealth

Legal name

BEKhealth Corporation

Website

https://bekhealth.com

Company type

Private

Founded year

2022

Operating status

Operating

Headcount range

11–50 employees

Short description

BEKhealth operates an AI-powered clinical intelligence platform that reads structured and unstructured EHR data to match patients to clinical trial protocols, delivering feasibility analytics, site selection, and longitudinal real-world data to pharmaceutical sponsors, CROs, and research sites.

Ownership category

akta.pro rank

Product category

Clinical Trial Technology Software

NAICS

Computer Systems Design and Related Services (54151), Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (518)

SIC

Services-Computer Programming, Data Processing, Etc. (7370), Services-Computer Processing & Data Preparation (7374)

akta.pro primary industry

Healthcare Terminology, Ontology & Code Set Management (SNOMED/LOINC/ICD/RxNorm) (HLACAIAF)

Keywords

• Clinical trial matching
• Real-world evidence
• Patient recruitment
• Electronic health records
• Clinical research platform

Headquarters

HQ city

Branford

HQ country

United States

HQ region

North America

Offices4 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations

Revenue model

1. AI-Powered Software Platform (BEKplatform): BEKplatform is a SaaS platform providing patient matching, feasibility analysis, and site selection services to sponsors, CROs, and research sites on a subscription or usage basis. Pricing is tiered and scalable, with a free tier available for research sites joining the BEKnetwork.
2. Real-World Data (RWD) Services: Curated EHR-derived longitudinal datasets for observational research, regulatory submissions, post-market evidence generation, and market access. Revenue is generated through data access agreements with sponsors and CROs.
3. BEKnetwork Membership for Sites: The BEKnetwork is free to research sites; sites receive feasibility reports and study matching at no cost. The platform is monetized through sponsors and CROs engaging the network rather than through site subscriptions.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels8 records

Core offering

BEKHealth operates BEKplatform, an AI-powered patient matching platform that uses deep-learning NLP and LLMs to analyze both structured and unstructured electronic health record (EHR) data at 95%+ accuracy, surfacing protocol-eligible patients for clinical trials in minutes. The company also operates the BEKnetwork, a connected research network of 200+ sites and 30M+ longitudinal patient records, and offers curated Real-World Data (RWD) services for sponsors and CROs seeking feasibility analytics, site selection, patient recruitment, and post-market evidence generation.

Product overview

BEKhealth offers a unified platform architecture centered on BEKplatform and BEKnetwork, with supplementary tools including Galileo (trial feasibility), SiteWorks (research CRM), BEK Translate Real-Time (protocol-to-patient matching), BEKScore (protocol AI-compatibility scoring), and Real-World Data products. BEKplatform serves as the core AI engine, analyzing both structured and unstructured EHR data to power patient matching and feasibility. BEKnetwork provides the connected research network of sites and longitudinal patient data. These products work together to support the full clinical trial lifecycle from feasibility through enrollment and evidence generation.

Differentiator

Problem solved

Functional benefit

Brands

• BEKplatform: AI-powered patient matching platform that analyzes structured and unstructured EHR data to surface the right sites and patients faster than manual processes.
• BEKnetwork
• BEK Translate
• Galileo
• SiteWorks

Products and services

• BEKplatform AI-powered patient matching platform that analyzes structured and unstructured EHR data to identify protocol-eligible patients and accelerate feasibility, site selection, and enrollment for clinical trials. Used by pharmaceutical sponsors, CROs, and research sites.
• BEKnetwork Research network connecting healthcare sites to sponsors and CROs, providing sites with study matching, feasibility reports, and access to clinical trial opportunities. The network spans 30M+ patients, 200+ research sites, and 1,000+ trials.
• Galileo Research network trial feasibility solution that provides real-time visibility across a clinical network to evaluate clinical trial protocols with greater speed, precision, and efficiency, helping sponsors and networks assess feasibility.
• SiteWorks CRM platform designed specifically for research teams to enable seamless communication between Clinical Research Coordinators (CRCs), nurses, providers, and patients throughout the clinical trial process.
• BEK Translate Real-Time Real-time clinical trial protocol-to-patient matching solution that translates complex protocol eligibility criteria into precise patient-matching queries across the BEKnetwork, addressing critical needs in drug development.
• BEKScore Commercial scoring service that evaluates clinical trial protocol designs and criteria to determine how likely an AI solution will find trial candidates within an EMR database, helping pharmaceutical companies design protocols compatible with AI-enabled site solutions.
• Real-World Data (RWD) Longitudinal EHR-derived real-world datasets spanning 30M+ community-based patients supporting observational research, regulatory submissions, post-market evidence generation, and market access, with daily refresh and built-in provenance and audit trail.

Quantifiable outcome

• 3× more accurate patient matching vs. traditional methods
• +5 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration20 records

AI capability7 records

Feature11 records

Partnerships

Twelve partnerships are on record, tiered core, major, strategic and minor.

• Innovo ResearchcoreStrategic or Co-development Partner · 4 November 2025BEKhealth expanded its partnership with Innovo Research to enhance the collection and use of real-world data in healthcare and clinical research. The collaboration involves utilizing BEKhealth's AI platform with Innovo's network of health practices across eight states, targeting improved patient outcomes and data-driven decision making.
• RTI Health SolutionscoreStrategic or Co-development Partner · 4 November 2025BEKhealth partners with RTI Health Solutions, a global leader in health economics and outcomes research, to set a higher standard for real-world evidence. RTI-HS brings scientific rigor to complement BEKhealth's connected network, AI-powered chart abstraction, and high-fidelity EHR data, delivering evidence that meets regulatory, payer, and peer-reviewed publication standards.
• Areti HealthcoreStrategic or Co-development Partner · 19 September 2024BEKhealth partnered with Areti Health to create an end-to-end AI-powered patient recruitment solution. BEKplatform identifies protocol-eligible candidates (10× more than traditional methods) while Areti's generative AI Coordinator engages pre-identified patients, handles pre-screening, scheduling, and enrollment support, achieving a 63% conversion rate. The partnership addresses patient recruitment bottlenecks in clinical research.
• Science 37majorStrategic or Co-development Partner · 1 January 2023Science 37 and BEKhealth collaborated to expand patient access to clinical trials via a network of 35K+ community providers and 35M+ patient lives, combining Science 37's decentralized trial capabilities with BEKhealth's AI-powered patient matching.
• CRIOstrategicTechnology or IntegrationBEKhealth joined CRIO's Partners Program, integrating BEKplatform's AI-powered patient matching directly within the CRIO workflow. This allows clinical research sites, sponsors, and CROs to incorporate BEKhealth's patient-matching solution seamlessly within CRIO's eSource and Site CTMS platform.
• WCG (WIRB-Copernicus Group)strategicChannel Partner/ Reseller/ DistributorWCG is listed as a recruitment and retention partner providing site solutions. The partnership addresses roadblocks impacting clinical research recruitment through WCG's site solutions capabilities combined with BEKhealth's patient identification technology.
• Rocket TrialsminorChannel Partner/ Reseller/ DistributorRocket Trials provides recruitment and retention marketing services. The partnership extends BEKhealth's reach into patient engagement and marketing for clinical research recruitment.
• Western States Cancer ResearchstrategicChannel Partner/ Reseller/ DistributorBEKhealth and Western States Cancer Research partnered to expand availability of clinical trials to over 20 hospitals and medical sites, combining BEKhealth's AI platform with Western States' cancer research network.
• Alcanza Clinical ResearchstrategicChannel Partner/ Reseller/ DistributorAlcanza Clinical Research selected BEKhealth's AI-powered EMR platform to enhance diversity in clinical trials by rapidly matching eligible patients using real-world data and precision targeting.
• EpicstrategicTechnology or IntegrationEpic is an EMR partner. BEKhealth has secured Epic approval enabling rapid adoption of its clinical research platform with limited IT requirements at Epic-using sites.
• ModMedstrategicTechnology or IntegrationModMed is an EMR partner. BEKhealth has secured approval enabling rapid platform adoption at ModMed-using sites.
• AthenahealthstrategicTechnology or IntegrationAthenahealth is an EMR partner. BEKhealth has secured approval enabling rapid platform adoption at Athenahealth-using sites.

Scale indicators13 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Deep 6 AI: Deep 6 AI builds AI-driven patient matching for clinical trials using structured and unstructured EHR data — the most direct head-to-head competitor to BEKplatform, serving the same pharma sponsors and CROs with the same feasibility/site-selection use cases. BEKhealth's CCO Tim Keliher previously led commercial at Deep 6 AI.
• TriNetX: TriNetX operates a global health research network for clinical trial feasibility, site selection, and real-world evidence — directly overlapping with BEKnetwork and BEKplatform's RWD + patient matching capabilities. BEKhealth's CDO, COO, and CCO all previously held senior roles at TriNetX.
• Verana Health: Verana Health curates EHR-derived real-world data for clinical research, regulatory, and medical affairs use cases across specialty therapeutic areas — a direct peer in the RWD-for-clinical-research category, serving the same pharma evidence-generation buyers. BEKhealth's CCO Tim Keliher previously led commercial at Verana Health.
• Mendel: Mendel applies NLP/LLMs to structured and unstructured clinical data to structure patient cohorts for clinical research and real-world evidence — directly comparable to BEKplatform's AI-powered chart abstraction and patient matching for pharma and CRO customers.

Broad incumbents

• IQVIA: IQVIA is the largest CRO and health data incumbent, operating E360 and other RWD/clinical-trial analytics platforms that overlap with BEKplatform's feasibility, site selection, and RWE offerings — though IQVIA competes as part of a much broader services portfolio rather than a specialty AI tool.
• Flatiron Health: Flatiron Health (Roche) operates EHR-derived oncology real-world data and clinical research platforms — a broader incumbent that overlaps with BEKhealth's RWD and oncology-trial recruitment use cases, particularly for sponsors running cancer studies.
• Tempus: Tempus combines molecular data, EHR-derived real-world data, and AI for precision medicine and clinical research — a broader healthcare-AI incumbent whose RWD and clinical-trial matching offerings compete with BEKhealth in the sponsor and CRO buyer landscape.

Emerging players

• PicnicHealth: PicnicHealth collects patient-consented longitudinal EHR data for real-world evidence generation — comparable to BEKhealth's RWD offering in longitudinal patient data capture and pharma evidence generation, with overlap in patient-recruitment-adjacent workflows. BEKhealth's COO Jennifer Stacey previously held a senior role at PicnicHealth.
• Datavant: Datavant focuses on health data connectivity and privacy-preserving record linkage across EHRs, claims, and registries — an adjacent enabler of cross-source real-world data assembly that intersects with BEKhealth's longitudinal RWD and patient-matching workflows at the data-connectivity layer.
• Syapse: Syapse applies real-world data and analytics to oncology precision medicine and pharma evidence generation — a partial-overlap peer competing for the same oncology RWD and pharma real-world evidence budgets that BEKhealth's therapeutic-area focus targets.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/channel/UCEiL4C0Gk4L7g9l6rYdZp0w
• LinkedInlinkedin.com/company/14836396

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Funding overview

Funding rounds6 records

Investors9 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BEKHealth